World Kinect
WKC NYSE Oil & Gas Refining & Marketing Financials FY2016βFY2025
World Kinect's revenue fell 12.4% to $36.9 billion in fiscal 2025. Its operating margin was β1.5%, down from 0.5% a year earlier. Free cash flow was $227 million, up 18.6%. It paid out $126 million in dividends and buybacks, 56% of free cash flow. The diluted share count fell 6.0%.
About these figures. Net debt to EBITDA for fiscal 2025 is blank: the 10-K's structured data doesn't include every figure it needs.
What World Kinect does
No business description yet.
- Legal name
- WORLD KINECT CORPORATION
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000789460-26-000015
0000789460
Revenue and margins
World Kinect had $36.9B of revenue in fiscal 2025, down 12.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $227M in fiscal 2025, 0.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
World Kinect returned $126M to shareholders in fiscal 2025, 56% of free cash flow. The diluted share count fell 6.1%.
Value World Kinect yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$504M and divides by 55.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably World Kinect can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $652M | $298M | $304M | $383M | $194M |
| Debt incl. finance leases | $509M | $846M | $888M | $881M | $697M |
| Net debt / EBITDA | β0.6x | 1.4x | 1.9x | 1.6x | β |
| Debt / equity | 0.3x | 0.4x | 0.5x | 0.5x | 0.5x |
| Interest coverage | 3.0x | 2.3x | 1.5x | 1.8x | β5.0x |
| Current ratio | 1.3x | 1.1x | 1.1x | 1.2x | 1.1x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 1.0x | 0.9x |
| Total assets | $5.9B | $8.2B | $7.4B | $6.7B | $5.9B |
| Total liabilities | $4.0B | $6.2B | $5.4B | $4.8B | $4.6B |
| Shareholders' equity | $1.9B | $2.0B | $1.9B | $1.9B | $1.3B |
| Net debt (β = net cash) | β$144M | $547M | $584M | $498M | $504M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$5.7M
5 insiders
Of sales under plans
50%
$2.9M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Michael J KasbarExecutive Chairman, Director | Sold plan | 10,000 | $35.40 | $0.4M | Form 4 |
| Aug 13, 2026 | Jose-Miguel TejadaEVP, Chief Financial Officer | Sold | 6,000 | $37.16 | $0.2M | Form 4 |
| Aug 3, 2026 | Michael J KasbarExecutive Chairman, Director | Sold plan | 10,000 | $39.41 | $0.4M | Form 4 |
| Jul 29, 2026 | John L ManleyDirector | Sold | 10,000 | $39.88 | $0.4M | Form 4 |
| Jul 29, 2026 | Paul H StebbinsDirector | Sold | 33,445 | $39.93 | $1.3M | Form 4 |
| Jul 10, 2026 | Michael J KasbarExecutive Chairman, Director | Sold plan | 25,000 | $35.04 | $0.9M | Form 4 |
| Jul 2, 2026 | Michael J KasbarExecutive Chairman, Director | Sold plan | 10,000 | $33.38 | $0.3M | Form 4 |
| Jun 8, 2026 | Michael J KasbarExecutive Chairman, Director | Sold plan | 19,300 | $30.17 | $0.6M | Form 4 |
| Jun 5, 2026 | Michael J KasbarExecutive Chairman, Director | Sold plan | 700 | $30.00 | $0.0M | Form 4 |
| Jun 2, 2026 | Michael J KasbarExecutive Chairman, Director | Sold plan | 10,000 | $29.15 | $0.3M | Form 4 |
| May 11, 2026 | Richard A KassarDirector | Sold | 10,000 | $26.97 | $0.3M | Form 4 |
| May 5, 2026 | Paul H StebbinsDirector | Sold | 20,828 | $27.69 | $0.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β2.8% | β2.7% | β14.4% |
| Altman Z'' | 1.84 | 2.12 | 0.60 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| World Kinect WKC | $1.9B | β12.5% | β1.5% | 0.6% | β20.9% | β | 5 | |
| PBF Energy PBF | $9.2B | β11.4% | β0.2% | β2.7% | β0.6% | 6.7x | 4 | Compare β |
| HF Sinclair DINO | $21.8B | β6.0% | 3.5% | 3.2% | 6.6% | 11.6x | 8 | Compare β |
| Valero Energy VLO | $123.3B | β5.5% | 2.6% | β | 7.2% | 17.4x | 6 | Compare β |
| Phillips 66 PSX | $114.0B | β7.5% | β | β | 11.2% | 16.2x | 8 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $27.0B | $33.7B | $39.8B | $36.8B | $20.4B | $31.3B | $59.0B | $47.7B | $42.2B | $36.9B |
| Gross profit | $899M | $932M | $1.0B | $1.1B | $852M | $788M | $1.1B | $1.1B | $1.0B | $948M |
| Operating income | $189M | $45.6M | $260M | $300M | $138M | $143M | $273M | $198M | $211M | β$565M |
| Interest expense | $43.7M | $66.3M | $74.8M | $80.0M | $48.6M | $47.2M | $117M | $136M | $116M | $112M |
| Pretax income | $142M | β$21.1M | $185M | $237M | $162M | $100M | $145M | $66.7M | $95.5M | β$740M |
| Income tax | $15.7M | $149M | $55.9M | $56.2M | $52.1M | $25.8M | $29.2M | $13.0M | $27.6M | β$128M |
| Net income | $127M | β$170M | $128M | $179M | $110M | $73.7M | $114M | $52.9M | $67.4M | β$614M |
| Diluted EPS | $1.81 | β$2.50 | $1.89 | $2.69 | $1.71 | $1.16 | $1.82 | $0.86 | $1.13 | β$10.99 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $50.7M | β$134M | β$183M | $229M | $604M | $173M | $139M | $271M | $260M | $293M |
| Capital expenditure | $36.1M | $54.0M | $72.3M | $80.9M | $51.3M | $39.2M | $78.6M | $87.6M | $68.2M | $65.6M |
| Free cash flow | $14.6M | β$188M | β$255M | $148M | $553M | $134M | $59.9M | $184M | $192M | $227M |
| Depreciation and amortization | $82.3M | $86.0M | $81.5M | $87.4M | $85.8M | $81.0M | $108M | $105M | $106M | $98.2M |
| Stock-based compensation | $19.2M | $21.2M | $8.3M | $23.6M | β$0.9M | $19.6M | $17.6M | $24.2M | $28.1M | $25.5M |
| Acquisitions | $431M | $121M | $21.3M | $0.0M | $129M | $37.1M | $644M | $13.7M | $40.0M | $154M |
| Share buybacks | $41.2M | $61.9M | $20.0M | $65.4M | $68.3M | $50.5M | $48.7M | $60.1M | $100M | $85.0M |
| Dividends paid | $16.6M | $16.3M | $16.2M | $21.1M | $25.6M | $28.7M | $31.0M | $34.0M | $38.5M | $41.3M |
| Dividends and buybacks | $57.8M | $78.2M | $36.2M | $86.5M | $93.9M | $79.2M | $79.7M | $94.1M | $139M | $126M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $699M | $372M | $212M | $186M | $659M | $652M | $298M | $304M | $383M | $194M |
| Total debt | $1.2B | $910M | $701M | $629M | $525M | $509M | $846M | $888M | $881M | $697M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $18.7M | $18.2M | $21.2M | $15.4M | $15.7M | $30.0M | $4.4M |
| Current assets | $3.8B | $3.9B | $4.0B | $4.2B | $2.6B | $4.0B | $5.2B | $4.5B | $4.0B | $3.5B |
| Current liabilities | $2.2B | $2.7B | $2.9B | $3.2B | $1.7B | $3.1B | $4.6B | $4.0B | $3.4B | $3.3B |
| Inventory | $458M | $505M | $523M | $593M | $344M | $478M | $780M | $665M | $514M | $454M |
| Property and equipment, net | $311M | $330M | $350M | $361M | $343M | $349M | $484M | $515M | $513M | $348M |
| Total assets | $5.4B | $5.6B | $5.7B | $6.0B | $4.5B | $5.9B | $8.2B | $7.4B | $6.7B | $5.9B |
| Total liabilities | $3.5B | $3.8B | $3.8B | $4.1B | $2.6B | $4.0B | $6.2B | $5.4B | $4.8B | $4.6B |
| Shareholders' equity | $1.9B | $1.7B | $1.8B | $1.9B | $1.9B | $1.9B | $2.0B | $1.9B | $1.9B | $1.3B |
| Margins | ||||||||||
| Gross margin | 3.3% | 2.8% | 2.6% | 3.0% | 4.2% | 2.5% | 1.8% | 2.2% | 2.4% | 2.6% |
| Operating margin | 0.7% | 0.1% | 0.7% | 0.8% | 0.7% | 0.5% | 0.5% | 0.4% | 0.5% | β1.5% |
| EBITDA margin | 1.0% | 0.4% | 0.9% | 1.1% | 1.1% | 0.7% | 0.7% | 0.6% | 0.8% | β1.3% |
| Net margin | 0.5% | β0.5% | 0.3% | 0.5% | 0.5% | 0.2% | 0.2% | 0.1% | 0.2% | β1.7% |
| FCF margin | 0.1% | β0.6% | β0.6% | 0.4% | 2.7% | 0.4% | 0.1% | 0.4% | 0.5% | 0.6% |
| Returns | ||||||||||
| Return on capital | 7.5% | 1.5% | 7.9% | 9.8% | 4.5% | 6.0% | 10.1% | 6.3% | 6.0% | β20.9% |
| Return on capital employed | 6.3% | 1.5% | 9.3% | 10.8% | 4.9% | 5.0% | 8.5% | 5.8% | 6.4% | β19.3% |
| Return on equity | 6.6% | β9.3% | 7.2% | 9.7% | 5.8% | 3.9% | 5.9% | 2.7% | 3.5% | β37.8% |
| Return on assets | 2.6% | β3.1% | 2.3% | 3.1% | 2.1% | 1.4% | 1.6% | 0.7% | 1.0% | β9.8% |
| Growth | ||||||||||
| Revenue growth | β11.1% | 24.7% | 18.0% | β7.4% | β44.7% | 53.9% | 88.4% | β19.2% | β11.6% | β12.5% |
| Net income growth | β27.5% | β234.6% | β | 40.1% | β38.7% | β32.8% | 54.8% | β53.6% | 27.4% | β1,011.6% |
| EPS growth | β26.7% | β238.1% | β | 42.3% | β36.4% | β32.2% | 56.9% | β52.8% | 31.4% | β1,072.6% |
| FCF growth | β96.3% | β1,384.9% | β | β | 273.8% | β75.8% | β55.3% | 206.7% | 4.4% | 18.6% |
| Share count change | β1.3% | β2.4% | β0.6% | β1.8% | β3.8% | β1.1% | β1.0% | β1.6% | β3.6% | β6.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.8x | 4.1x | 1.4x | 1.1x | β0.6x | β0.6x | 1.4x | 1.9x | 1.6x | β |
| Debt / equity | 0.6x | 0.5x | 0.4x | 0.3x | 0.3x | 0.3x | 0.4x | 0.5x | 0.5x | 0.5x |
| Interest coverage | 4.3x | 0.7x | 3.5x | 3.8x | 2.8x | 3.0x | 2.3x | 1.5x | 1.8x | β5.0x |
| Current ratio | 1.8x | 1.5x | 1.4x | 1.3x | 1.6x | 1.3x | 1.1x | 1.1x | 1.2x | 1.1x |
| Quick ratio | 1.6x | 1.3x | 1.2x | 1.1x | 1.4x | 1.1x | 1.0x | 1.0x | 1.0x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.1% | 0.2% | 0.2% | 0.2% | 0.3% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% |
| Stock comp / revenue | 0.1% | 0.1% | 0.0% | 0.1% | 0.0% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% |
| Payouts / FCF | 395.9% | β | β | 58.5% | 17.0% | 59.1% | 133.1% | 51.2% | 72.3% | 55.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 4.0 | 5.0 | 7.0 | 7.0 | 6.0 | 6.0 | 6.0 | 7.0 | 5.0 |
| Altman Z'' | 3.8 | 2.8 | 2.9 | 2.9 | 3.7 | 2.7 | 1.9 | 1.8 | 2.1 | 0.6 |
| Accruals ratio | 1.5% | β0.7% | 5.5% | β0.9% | β9.4% | β1.9% | β0.4% | β2.8% | β2.7% | β14.4% |
Source: SEC EDGAR XBRL filings (CIK 0000789460). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.